GERM-01. RESPONSE RATES TO DIFFERENT RE-INDUCTION CHEMOTHERAPY REGIMENS IN PATIENTS WITH RECURRENT CENTRAL NERVOUS SYSTEM MIXED MALIGNANT GERM CELL TUMORS

類似資料

• GERM-17. CHARACTERISTICS OF SUCCESSFULLY SALVAGED PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
  著者:: Abu Arja, Mohammad H, 等
  出版事項: (2018)
• GCT-40. PROGNOSTIC FACTORS FOR PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
  著者:: Abu-Arja, Mohammad H, 等
  出版事項: (2020)
• GERM-24. PRIMARY CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN DOWN SYNDROME
  著者:: Lamb, Margaret, 等
  出版事項: (2018)
• GERM-02. NOVEL TREATMENT APPROACH FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) PURE EMBRYONAL CARCINOMA WITH INTENSIVE INDUCTION AND CONSOLIDATION MARROW-ABLATIVE CHEMOTHERAPY FOLLOWED BY AN ANTI-CD30 ANTIBODY-DRUG CONJUGATE, WITHOUT IRRADIATION
  著者:: Abu Arja, Mohammad H, 等
  出版事項: (2018)
• GCT-25. INNOVATIVE, INTENSIVE IRRADIATION-AVOIDING/MINIMIZING CHEMOTHERAPY FOR HIGH-RISK PRIMARY CENTRAL NERVOUS SYSTEM (CNS) MIXED MALIGNANT GERM CELL TUMORS (HR-MMGCT): A PILOT STUDY AND PROPOSED MULTI-NATIONAL PROSPECTIVE TRIAL
  著者:: Finlay, Jonathan L, 等
  出版事項: (2020)